United States: Biden's Executive Order On Competition Could Spell Changes For The Pharmaceutical Industry - Foley & Lardner

On Friday, July 9, 2021, President Biden issued a broad Executive Order that could have significant implications for businesses across a broad spectrum of industries, including the pharmaceutical industry.